STOPDAPT-3 one-year results support similar efficacy and safety of aspirin and clopidogrel after percutaneous coronary intervention

Eur Heart J. 2024 Dec 16;45(47):5055-5057. doi: 10.1093/eurheartj/ehae773.
No abstract available